Gene · 8840
Papers1,415
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,415
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Latest Advances in Chondrocyte-Based Cartilage Repair. | Biomedicines | 2024 | 38927573 | PubTator, text mining | PubMed |
| WISP-1 Regulates Cardiac Fibrosis by Promoting Cardiac Fibroblasts' Activation and Collagen Processing. | Cells | 2024 | 38891121 | PubTator, text mining | PubMed |
| The IL-33-ST2 axis plays a vital role in endometriosis via promoting epithelial-mesenchymal transition by phosphorylating β-catenin. | Cell Commun Signal | 2024 | 38858740 | PubTator, text mining | PubMed |
| Multi-omics Analysis Revealed that the CCN Family Regulates Cell Crosstalk, Extracellular Matrix, and Immune Escape, Leading to a Poor Prognosis of Glioma. | Cell Biochem Biophys | 2024 | 38837011 | PubTator, text mining | PubMed |
| Docosahexaenoic acid (DHA) promotes recovery from postoperative ileus and the repair of the injured intestinal barrier through mast cell-nerve crosstalk. | Int Immunopharmacol | 2024 | 38823183 | PubTator, text mining | PubMed |
| Osteoarthritis versus psoriasis arthritis: Physiopathology, cellular signaling, and therapeutic strategies. | Genes Dis | 2024 | 38292181 | PubTator, text mining | PubMed |
| Tumor microenvironment of cancer stem cells: Perspectives on cancer stem cell targeting. | Genes Dis | 2024 | 38292177 | PubTator, text mining | PubMed |
| High-Grade Serous Ovarian Cancer-A Risk Factor Puzzle and Screening Fugitive. | Biomedicines | 2024 | 38275400 | PubTator, text mining | PubMed |
| UBDP1 pseudogene and UBD network competitively bind miR‑6072 to promote glioma progression. | Int J Oncol | 2024 | 38275102 | PubTator, text mining | PubMed |
| Time-dependent effects of BRAF-V600E on cell cycling, metabolism, and function in engineered myocardium. | Sci Adv | 2024 | 38266090 | PubTator, text mining | PubMed |
| Nutrition and Exercise Interventions on Skeletal Muscle Physiology, Injury and Recovery: From Mechanisms to Therapy. | Nutrients | 2024 | 38257187 | PubTator, text mining | PubMed |
| Cell membrane-anchored and tumor-targeted IL-12 T-cell therapy destroys cancer-associated fibroblasts and disrupts extracellular matrix in heterogenous osteosarcoma xenograft models. | J Immunother Cancer | 2024 | 38199607 | PubTator, text mining | PubMed |
| Regulation of cancer stem cells and immunotherapy of glioblastoma (Review). | Biomed Rep | 2024 | 38170016 | PubTator, text mining | PubMed |
| Understanding the effects of per- and polyfluoroalkyl substances on early skin development: Role of ciliogenesis inhibition and altered microtubule dynamics. | Sci Total Environ | 2024 | 38163615 | PubTator, text mining | PubMed |
| Investigation of iso-propylchaetominine anticancer activity on apoptosis, cell cycle and Wnt signaling pathway in different cancer models. | Fitoterapia | 2024 | 38158162 | PubTator, text mining | PubMed |
| WISP1 induces the expression of macrophage migration inhibitory factor in human lung fibroblasts through Src kinases and EGFR-activated signaling pathways. | Am J Physiol Cell Physiol | 2024 | 38145300 | PubTator, text mining | PubMed |
| Crosstalk between glioblastoma and tumor microenvironment drives proneural-mesenchymal transition through ligand-receptor interactions. | Genes Dis | 2024 | 37692522 | PubTator, text mining | PubMed |
| Metastasis and cancer associated fibroblasts: taking it up a NOTCH. | Front Cell Dev Biol | 2023 | 38269089 | PubTator, text mining | PubMed |
| Controversial causal association between IGF family members and osteoporosis: a Mendelian randomization study between UK and FinnGen biobanks. | Front Endocrinol (Lausanne) | 2023 | 38260127 | PubTator, text mining | PubMed |
| Anti-PD-L1 therapy altered inflammation but not survival in a lethal murine hepatitis virus-1 pneumonia model. | Front Immunol | 2023 | 38259435 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8840/papers?page=5